Observational studyJournal of the Chinese Medical Association : JCMA2026
Change in dapagliflozin trial eligibility status and prognosis among patients with acute heart failure with preserved ejection fraction.
Lo-Chieh Ling et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.